Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT06970184
Active, not recruiting Observational

Alveolar Ridge Preservation With Cortico-cancellous Porcine Bone

NCT06970184 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Pisa
Phase
Observational
Started
2021-06-15
Last updated
2025-05-20

Condition(s) studied

Alveolar Ridge PreservationImplant TherapyTooth Extraction Site Healing

Investigational drug(s) / intervention(s)

tooth extraction with alveolar ridge preservationImplant placement

tooth extraction with alveolar ridge preservation: alveolar ridge preservation performed after tooth extraction

Implant placement: Implant placement

Study summary

Observational, prospective study conducted on patients requiring tooth extractions followed by ARP and subsequent implant placement.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 18 yo * Needing tooth extraction followed by ARP and implant-prosthetic rehabilitation Exclusion Criteria: * uncontrolled systemic diseases * uncontrolled periodontitis * undergoing previous or actual treatment with medications/radiations potentially impairing hard and soft tissues healing * women during pregnancy or breastfeeding

Primary outcome measure(s)

  • Histomorphometric characteristics of the bone: Newly formed bone (NB) — T1= 4 months following tooth extraction + ARP
    The primary outcome is evaluated in terms of Percentages of newly formed bone (NB) in the in the histological samples.
  • Histomorphometric characteristics of the bone: marrow spaces (MS) — T1= 4 months following tooth extraction + ARP
    The primary outcome is evaluated in terms of Percentages of marrow spaces (MS) in the histological samples
  • Histomorphometric characteristics of the bone: residual graft particles (RP) — T1= 4 months following tooth extraction + ARP
    The primary outcome is evaluated in terms of Percentages of marrow spaces (MS) in the histological samples

Trial sites (1)

FacilityCityRegionStatus
U.O. Odontostomatologia e Chirurgia del Cavo Orale Pisa Italy

More University of Pisa trials in Italy

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients Recruiting
Clinical Outcomes of Immediate Implants With or Without a Volume-stable Collagen Matrix Active, not recruiting
Application of Ultra-high Frequency Ultrasonography (UHFUS) to the Study of Gingival Tissues Recruiting
Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients Recruiting
Evaluation of a Multimodal Tactile Feedback System for Upper Limb-loss Users: Embodiment and Performance Recruiting

Other trials for the same condition

Alveolar Ridge Preservation: Biologically-oriented Alveolar Ridge Preservation Vs Modified Periosteal Inhibition Active, not recruiting
Clinical and Radiographic Outcomes of Alveolar Ridge Preservation Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06970184 on ClinicalTrials.gov ↗ ← All trials in Italy